This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: David Favre: Innovator in HIV Therapy
Introduction
David Favre is a notable inventor based in Research Triangle Park, NC (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds useful in HIV therapy. His work has the potential to impact the lives of many individuals affected by this virus.
Latest Patents
David Favre holds a patent for "Compounds useful in HIV therapy." This invention relates to compounds of Formula (I), (II), or (III), along with their salts and pharmaceutical compositions. The therapeutic methods outlined in this patent aim to provide effective treatment and prevention strategies for HIV.
Career Highlights
Favre is associated with GlaxoSmithKline Intellectual Property Development Limited, where he continues to advance his research and innovations. His dedication to improving healthcare through scientific discovery is evident in his work and the impact it has on the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Robert G Ferris and Jun Tang. Their collaborative efforts contribute to the innovative environment at GlaxoSmithKline, fostering advancements in medical research.
Conclusion
David Favre's contributions to HIV therapy exemplify the importance of innovation in the pharmaceutical field. His work not only showcases his expertise but also highlights the collaborative nature of scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile